TipRanks
Advertisement
Advertisement
Renalytix CEO Increases Stake as AI Kidney Test Gains U.S. Traction
PremiumCompany AnnouncementsRenalytix CEO Increases Stake as AI Kidney Test Gains U.S. Traction
23d ago
Renalytix Aligns Year-End Reporting With Calendar Year Ahead of Quest Partnership
Premium
Company Announcements
Renalytix Aligns Year-End Reporting With Calendar Year Ahead of Quest Partnership
25d ago
Renalytix CEO Boosts Stake as Kidney Diagnostics Platform Scales in U.S.
Premium
Company Announcements
Renalytix CEO Boosts Stake as Kidney Diagnostics Platform Scales in U.S.
28d ago
Renalytix raises £9.5m to fund U.S. kidney-test rollout and cuts debt via bond conversion
PremiumCompany AnnouncementsRenalytix raises £9.5m to fund U.S. kidney-test rollout and cuts debt via bond conversion
1M ago
Renalytix partners with Quest to expand U.S. rollout of kidneyintelX.dkd test
Premium
Company Announcements
Renalytix partners with Quest to expand U.S. rollout of kidneyintelX.dkd test
1M ago
Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances
Premium
Company Announcements
Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances
2M ago
Renalytix CEO Boosts Stake as Kidney Disease Test Rollout Advances
PremiumCompany AnnouncementsRenalytix CEO Boosts Stake as Kidney Disease Test Rollout Advances
8M ago
Renalytix CFO Increases Stake as KidneyintelX.dkd Deployment Expands
Premium
Company Announcements
Renalytix CFO Increases Stake as KidneyintelX.dkd Deployment Expands
8M ago
Renalytix CFO Increases Stake as Kidney Disease Test Gains Traction
Premium
Company Announcements
Renalytix CFO Increases Stake as Kidney Disease Test Gains Traction
8M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―